Lisata Therapeutics Inc (LTS:0HS8)
$ 3.255 0 (0%) Market Cap: 28.95 Mil Enterprise Value: -14.23 Mil PE Ratio: 0 PB Ratio: 0.67 GF Score: 37/100

Caladrius Biosciences Inc Annual Shareholders Meeting Transcript

Jun 18, 2020 / 01:00PM GMT
Release Date Price: $28.2
Operator

Good day, ladies and gentlemen. And thank you for standing by. Welcome to the Caladrius Biosciences, Inc. Annual Meeting. At this time, I would like to turn the conference over to Dr. Gregory Brown. Sir, please begin.

Gregory Bailey Brown
Caladrius Biosciences, Inc. - Independent Chairman of the Board

Thank you, operator. And good morning, everyone. My name is Greg Brown, and I'm Chairman of the Board of Directors of Caladrius Biosciences, Inc. And as the Chairman of this annual meeting, I hereby call the 2020 Annual Meeting of Stockholders to order. On behalf of my fellow officers and directors, it is a pleasure to welcome you to our annual meeting.

We are excited to be hosting a virtual stockholder meeting for the first time, a format that has the benefit of allowing us to be more inclusive and reach a greater number of our stockholders while still respecting the norms in place for social distancing to help minimize the spread of the coronavirus. We have stockholders attending via the web portal.

As is our custom, we will conduct the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot